No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
Gene Editing Stocks Drop as Intellia Announces Layoffs
OptionMetrics and CRSP Announce Partnership Giving Academic Researchers Increased Integration of U.S. Equities and Options Data in Research
CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note